| Literature DB >> 30888842 |
Ceyda Oksel1, Raquel Granell2, Sadia Haider1, Sara Fontanella1, Angela Simpson3, Steve Turner4, Graham Devereux5, Syed Hasan Arshad6,7, Clare S Murray3, Graham Roberts6,7,8, John W Holloway6,8, Paul Cullinan9, John Henderson2, Adnan Custovic1.
Abstract
Rationale: Pooling data from multiple cohorts and extending the time frame across childhood should minimize study-specific effects, enabling better characterization of childhood wheezing.Entities:
Keywords: adolescence; childhood; latent class; wheezing phenotypes
Mesh:
Year: 2019 PMID: 30888842 PMCID: PMC6600832 DOI: 10.1513/AnnalsATS.201811-837OC
Source DB: PubMed Journal: Ann Am Thorac Soc ISSN: 2325-6621
Per cohort and combined characteristics of children with complete reports of wheezing
| Most Likely Wheezing Phenotypes | |||||||
|---|---|---|---|---|---|---|---|
| Never/Infrequent Wheeze | Early Onset Preschool Remitting | Early Onset Midchildhood Remitting | Persistent | Late Onset | |||
| SEATON, | 499 | 305 (61) | 108 (22) | 16 (3) | 31 (6) | 39 (8) | |
| ALSPAC, | 5,149 | 3,119 (61) | 1,058 (20) | 476 (9) | 253 (5) | 243 (5) | |
| MAAS, | 667 | 421 (63) | 96 (14) | 34 (5) | 84 (13) | 32 (5) | |
| Ashford, | 492 | 233 (47) | 176 (36) | 28 (6) | 50 (10) | 5 (1) | |
| IOW, | 912 | 548 (60) | 46 (5) | 37 (4) | 66 (7) | 215 (24) | |
| 5-Cohort data, | 7,719 | 4,626 (60) | 1,484 (19) | 591 (8) | 484 (6) | 534 (7) | |
| Sex | Male, | 3,881 (50) | 2,162 (47) | 830 (56) | 343 (58) | 288 (60) | 258 (48) |
| Birth weight, kg | Mean (SD) | 3.44 (0.53) | 3.44 (0.51) | 3.46 (0.54) | 3.41 (0.58) | 3.48 (0.57) | 3.43 (0.52) |
| Low birth weight (≤2.5) | Yes, | 314 (4.1) | 161 (3) | 63 (4) | 36 (6) | 31 (6) | 23 (4) |
| Maternal age | Mean (SD) | 29.1 (4.64) | 29.2 (4.57) | 28.9 (4.58) | 28.8 (4.73) | 28.7 (4.78) | 28.8 (5.07) |
| Advanced maternal age (≥35) | Yes, | 947 (12) | 572 (13) | 177 (12) | 72 (12) | 53 (11) | 73 (14) |
| Maternal smoking | Yes, | 6,491 (16) | 647 (14) | 249 (17) | 117 (20) | 88 (18) | 97 (18) |
| Paternal smoking | Yes, | 1,702 (27) | 979 (26) | 306 (25) | 144 (31) | 132 (32) | 141 (29) |
| Pet ownership | Yes, | 4,149 (54) | 2,449 (54) | 818 (56) | 334 (58) | 264 (55) | 284 (54) |
| Sensitization (midchildhood) | Yes, | 1,042 (17) | 461 (13) | 134 (12) | 106 (23) | 181 (47) | 160 (39) |
| Current asthma (last follow-up) | Yes, | 1,000 (14) | 121 (3) | 113 (8) | 86 (15) | 352 (75) | 328 (67) |
| Asthma ever | Yes, | 1,737 (26) | 452 (11) | 291 (24) | 274 (59) | 374 (91) | 346 (72) |
| Asthma medication (last follow-up) | Yes, | 949 (13) | 120 (3) | 113 (8) | 87 (15) | 345 (73) | 284 (58) |
| Asthma medication ever | Yes, | 2,125 (42) | 591 (14) | 294 (20) | 374 (64) | 451 (93) | 415 (89) |
Definition of abbreviations: ALSPAC = Avon Longitudinal Study of Parents and Children; IOW = Isle of Wight; MAAS = Manchester Asthma and Allergy Study; SD = standard deviation; SEATON = Aberdeen Study of Eczema and Asthma to Observe the Effects of Nutrition study.
Figure 1.Estimated prevalence of wheeze for each of the five wheezing phenotypes identified by latent class analysis in 7,719 children (infancy, age 0.5−1; early childhood, age 2−3; preschool age/early school age, age 4−5; middle childhood, age 8−10; adolescence, age 14−18). Class proportions shown in the figure legend are computed based on estimated posterior probabilities.
Figure 2.(A) Transition of most likely membership class between latent models constructed with complete (n = 7,719) and incomplete (n = 15,942) data. (B) Assignment of children into wheeze phenotypes over a sequence of latent class analysis models with four and five classes based on most likely membership class. Ellipse nodes show class membership (most likely phenotype), whereas the values along the arrow represent the percentage of children moving from one class to another. This figure reflects whether the members of distinct wheeze phenotypes will remain in the same group or shift into another.
Adjusted associations of wheezing phenotypes with late outcomes including current asthma, asthma ever, current use of asthma medication, asthma medication ever, and eczema ever using weighted membership probabilities
| Adjusted Odds Ratio (95% Cl) | |||||
|---|---|---|---|---|---|
| Current | Asthma Ever | Current | Asthma Medication Ever | Eczema Ever | |
| Never/infrequent | Reference | Reference | Reference | Reference | Reference |
| Early onset preschool remitting | 2.34 | 2.05 | 2.35 | 1.36 | 1.24 |
| 95% Cl | 1.73 to 3.17 | 1.70 to 2.46 | 1.74 to 3.18 | 1.14 to 1.62 | 1.07 to 1.42 |
| <0.0001 | <0.0001 | <0.0001 | 0.001 | 0.003 | |
| Early onset midchildhood remitting | 3.65 | 6.41 | 3.53 | 5.97 | 1.31 |
| 95% Cl | 2.55 to 5.21 | 5.11 to 8.03 | 2.47 to 5.05 | 4.85 to 7.35 | 1.06 to 1.61 |
| <0.0001 | <0.0001 | <0.0001 | <0.0001 | 0.010 | |
| Persistent | 48.31 | 37.95 | 42.45 | 38.67 | 3.22 |
| 95% Cl | 35.87 to 65.07 | 27.78 to 51.84 | 31.57 to 57.09 | 28.27 to 52.90 | 2.55 to 4.08 |
| <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
| Late onset | 36.39 | 12.00 | 24.51 | 17.75 | 2.03 |
| 95% Cl | 26.89 to 49.25 | 9.41 to 15.31 | 18.07 to 33.23 | 13.59 to 23.17 | 1.62 to 2.53 |
| <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
Definition of abbreviations: ALSPAC = Avon Longitudinal Study of Parents and Children; CI = confidence interval; IOW = Isle of Wight; MAAS = Manchester Asthma and Allergy Study; SEATON = Aberdeen Study of Eczema and Asthma to Observe the Effects of Nutrition Study.
Adjusted for sensitization (midchildhood), sex, maternal history of asthma or allergy, maternal smoking, and low birth weight.
Available at the latest follow-up (e.g., 18 yr in IOW, 16 yr in MAAS, 15 yr in SEATON, 15 yr in Ashford, and 14 yr in ALSPAC).
Associations of wheezing phenotypes with lung function measures adjusted for sex, height, and gender using weighted membership probabilities
| Mean Difference (95% Cl) | |||
|---|---|---|---|
| Never/infrequent | Reference | Reference | Reference |
| Early onset preschool remitting | −0.11 (−0.17 to −0.04) | −0.05 (−0.12 to 0.02) | −0.09 (−0.16 to −0.02) |
| 0.002 | 0.144 | 0.001 | |
| Early onset midchildhood remitting | −0.19 (−0.28 to −0.09) | −0.03 (−0.13 to 0.06) | −0.26 (−0.35 to −0.16) |
| <0.0001 | 0.531 | <0.0001 | |
| Persistent | −0.34 (−0.44 to −0.24) | 0.03 (−0.07 to 0.13) | −0.60 (−0.70 to −0.50) |
| <0.0001 | 0.577 | <0.0001 | |
| Late onset | −0.22 (−0.32 to −0.12) | −0.04 (−0.14 to 0.06) | −0.30 (−0.40 to −0.20) |
| <0.0001 | 0.406 | <0.0001 | |
Definition of abbreviations: CI = confidence interval; FEV1 = forced expiratory volume in 1 second; FVC = forced vital capacity.
Adjusted for maternal history of asthma or allergy, maternal smoking, and low birth weight.
Sex-, age-, and height-adjusted standard deviation units.
Figure 3.Presence/absence of wheeze at five time periods across latent classes stratified by cohort and class membership probabilities that have been derived by including cohort site as a covariate. Al = Avon Longitudinal Study of Parents and Children; As = Ashford; I = Isle of Wight; M = Manchester Asthma and Allergy Study; S = Aberdeen Study of Eczema and Asthma to Observe the Effects of Nutrition Study; TP = time period.